- Review
- Open access
- Published:
A scoping review of costing methodologies used to assess interventions for underserved pregnant people and new parents
International Journal for Equity in Health volume 23, Article number: 168 (2024)
Abstract
Background
Lack of evidence about the long-term economic benefits of interventions targeting underserved perinatal populations can hamper decision making regarding funding. To optimize the quality of future research, we examined what methods and costs have been used to assess the value of interventions targeting pregnant people and/or new parents who have poor access to healthcare.
Methods
We conducted a scoping review using methods described by Arksey and O’Malley. We conducted systematic searches in eight databases and web-searches for grey literature. Two researchers independently screened results to determine eligibility for inclusion. We included economic evaluations and cost analyses of interventions targeting pregnant people and/or new parents from underserved populations in twenty high income countries. We extracted and tabulated data from included publications regarding the study setting, population, intervention, study methods, types of costs included, and data sources for costs.
Results
Final searches were completed in May 2024. We identified 103 eligible publications describing a range of interventions, most commonly home visiting programs (n = 19), smoking cessation interventions (n = 19), prenatal care (n = 11), perinatal mental health interventions (n = 11), and substance use treatment (n = 10), serving 36 distinct underserved populations. A quarter of the publications (n = 25) reported cost analyses only, while 77 were economic evaluations. Most publications (n = 82) considered health care costs, 45 considered other societal costs, and 14 considered only program costs. Only a third (n = 36) of the 103 included studies considered long-term costs that occurred more than one year after the birth (for interventions occurring only in pregnancy) or after the end of the intervention.
Conclusions
A broad range of interventions targeting pregnant people and/or new parents from underserved populations have the potential to reduce health inequities in their offspring. Economic evaluations of such interventions are often at risk of underestimating the long-term benefits of these interventions because they do not consider downstream societal costs. Our consolidated list of downstream and long-term costs from existing research can inform future economic analyses of interventions targeting poorly served pregnant people and new parents. Comprehensively quantifying the downstream and long-term benefits of such interventions is needed to inform decision making that will improve health equity.
Background
Despite improvements in perinatal outcomes in high income countries, socio-economic disparities in outcomes persist. Inequity in perinatal outcomes arises as a result of structural factors that cause social inequality, which in turn impacts the social and health outcomes associated with pregnancy and early parenting through a variety of pathways [1]. Various terminology has been used to describe groups or populations at increased risk of poor perinatal outcomes as a consequence of social inequality, with common terms including ‘vulnerable’, ‘disadvantaged’, or ‘marginalized’ populations. These terms have been critiqued because they are potentially stigmatizing and conceptualize the locus of inequities as arising from individual flaws or deficits [2]. We therefore avoid these terms and instead intentionally conceptualize our focus to be people who are negatively impacted by health and social system factors that limit their access to optimal care to support good perinatal outcomes. In this research we describe the people of interest as those who are poorly served by healthcare systems.
Interventions aimed at addressing disparities in perinatal outcomes are important to redress health inequities and because they potentially have long-term benefits for both the pregnant person and their offspring [3]. The perinatal period offers an opportunity to identify and mitigate the risks to long-term maternal health [4] Additionally, the growing body of evidence on the developmental origins of health and disease has shown that health in pregnancy has a long-term impact on physical health of the offspring [5]. Likewise, research on child development has established that healthy attachment in early childhood has long term impact on emotional well-being and mental health [6]. However, the measurement of long-term outcomes in prospective studies of interventions is often costly, and for that reason may not occur. This can create challenges for funders who need to make decisions about whether it is worthwhile to invest in interventions, as lack of evidence can hamper the calculation of long-term economic benefits associated with the improvements in health and social outcomes.
One type of intervention that has shown promise with respect to improving the pregnancy and early parenting outcomes of populations who are poorly served by healthcare is midwifery-led care [7, 8]. There is a growing body of evidence to support the potential benefits of midwifery-led care for poorly served populations [9–11]. However, we identified a gap in the research with respect to economic evaluation of these kinds of interventions. In order to inform a larger research project aimed at developing a framework to assess the cost implications of midwifery care models that target underserved populations, we conducted a scoping review of the peer-reviewed and grey literature to synthesize previous approaches used to examine the short- and long-term cost implications of interventions targeting underserved pregnant people and new parents. Our research question was what types of costs and costing methodology have been used to assess interventions targeting pregnant people and/or new parents who have poor access to healthcare?
Methods
We conducted a scoping review in accordance with the methodology described by Arksey and O’Malley (2005) [12], including the following five stages: (1) identifying the research question; (2) identifying relevant studies; (3) study selection; (4) charting the data; (5) collating, summarizing, and reporting the results. We selected a scoping review as the best approach to systematically identify all previous economic and cost analyses, including both peer-reviewed and grey literature, that examine the cost implications of interventions targeting underserved pregnant people and/or new parents. The methodology allowed us to compare the range of analytical approaches used to evaluate costs to inform the development future cost analysis frameworks.
Identifying relevant studies
We developed a comprehensive search strategy for peer-reviewed and grey literature in consultation with a research librarian at the McMaster Health Sciences Library. The librarian provided guidance on the selection of keywords, refinement of the search strategy, and identification of relevant databases to search. Search terms related to ‘underserved populations,’ ‘economic evaluations,’ and ‘pregnant people and new parents’ were used to structure the search. Our search was not limited by year or language of publication. We drew on concurrent research we were conducting to scope the research literature regarding populations who have poor access to sexual and reproductive health care to define ‘underserved populations’ taking a broad approach. The full search strategy is included in Appendix A, which provides details regarding what populations were considered ‘underserved.’
We searched the following peer-reviewed academic literature databases: Ovid MEDLINE, Ovid Emcare, EMBASE (Ovid), Ovid Healthstar, Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL) EBSCO, EconLit EBSCO, and Business Source Premier EBSCO. To identify relevant grey literature, AJ hand-searched the websites of relevant organizations (e.g., Nurse Family Partnership, The Canada Prenatal Nutrition Program (CPNP), and Special Supplemental Nutrition Program for Women, Infants, and Children (WIC)). In addition, we reviewed the reference lists of key publications and relevant review articles to identify further sources. We imported the citation information for the retrieved publications into the citation management software, EndNote, and removed duplicate records prior to screening the results.
Study selection
We screened the retrieved publications for inclusion or exclusion using the systematic review software, Covidence, to manage the screening process. We first screened records by title and abstract against the inclusion and exclusion criteria. Second, we retrieved publications that passed the first stage of screening to screen the full text. Two reviewers (AJ, and RG or BJ or BA) independently screened the articles at both stages. We flagged any conflicts between researchers at either stage in Covidence and resolved difference through discussion. A third reviewer (ED) was consulted when consensus could not be reached.
Inclusion and exclusion criteria
To be included in this review, the publication needed to have: (1) described an intervention targeting pregnant people and/or new parents; (2) targeted an underserved population; (3) included a cost analysis of the intervention; and (4) been set in one of the top 20 Gross Domestic Product (GDP) per capita Organisation for Economic Co-operation and Development (OECD) countries in USD in 2020 [2, 13]. The purpose of the fourth criterion was to ensure that the research was conducted in countries with a similar context, i.e., a high-income economy and high Human Development Index (HDI). Included countries were Ireland, Luxembourg, Norway, United States, Switzerland, Denmark, Belgium, Sweden, Austria, Germany, France, Netherlands, Iceland, Finland, United Kingdom, Canada, Turkey, Australia, Italy, and Spain. A study was excluded if: (1) the goal of the described intervention was the prevention or termination of pregnancy; or (2) it was a review-level publication. We retained relevant reviews and hand-searched the reference lists for original studies meeting our criteria.
Charting the data
We charted relevant data from the publications identified for inclusion in a Microsoft Excel spreadsheet. Initially, two reviewers (AJ, RG) conducted data extraction independently, compared their results, and resolved disagreements by consensus. Both reviewers extracted data from approximately 10% of the included articles, until a high level of agreement was achieved. Then one reviewer (AJ) extracted the remaining data independently. Extracted data included publication details (i.e., authors, title, journal), study design, setting (location, duration), population characteristics, description of the intervention, type of economic evaluation conducted, types of costs included in the economic analysis, and sources of cost data.
Collating, summarizing, and reporting the results
Once data extraction and charting were completed, the team reviewed the findings to determine the most useful way to collate the results and synthesize key findings. We created tables summarizing the interventions, the analytical approaches used to calculate costs (e.g. cost -benefit, cost-minimization, cost effectiveness, cost utility, cost-consequences, or costing analyses) and consolidated a list of costs considered in the analyses (i.e., program costs, health care costs, societal costs) as well as whether immediate, short or long-term costs were determined. We used descriptive statistics, such as frequencies and percentages, to summarize the data and calculated these using Microsoft Excel.
Results
Final searches were completed on May 28, 2024. Figure 1 summarizes the results of our searches. We identified a total of 4866 publications from the peer-reviewed databases, all of which were in English. After removing duplicates, we identified 2507 publications for screening. We included 65 publications identified through database searches, 28 publications identified through reference chaining, and 11 publications identified through targeted web-searches. The final number of articles included in the review from these three sources was 104.
A descriptive summary of the included articles is presented in Table 1. Sixty-four (n = 64) of the publications focused on interventions in the United States [14–77], 29 in the United Kingdom [78–106], six in Australia [107,108,109,110,111,112], three in Canada [113,114,115], and one in each Sweden [116] and Germany [116]. The interventions described in these publications targeted pregnant people (n = 50), new parents (n = 16), or both (n = 37). Thirty-six (n = 36) underserved populations were targeted by the interventions, including people with low income, who were targeted in 35 interventions; people who smoke, who were targeted in 20 interventions; Medicaid recipients, who were targeted in 15 interventions; and people who use substances, who were targeted in 11 interventions. The publications described a range of interventions, most commonly home visiting programs (n = 19), smoking cessation interventions (n = 19), prenatal care (n = 11), perinatal mental health interventions (n = 11), and substance use treatment (n = 10). Of the 50 interventions that began in or continued into the postpartum period, the most common duration of interventions was between six months to two years postpartum (n = 30). Thirty-seven (n = 37) interventions were delivered in part or in full in the client’s home, 21 in the hospital, 21 digitally, and 16 in primary care clinics. Nurses (n = 33), midwives or nurse-midwives (n = 21), social workers (n = 11), and family physicians (n = 9) were the professionals most commonly involved in delivering the interventions.
Table 2 lists all 33 cost categories that were used in the publications, grouped into program costs, health care costs, and other societal costs. Sixteen (n = 16) studies considered only program costs. Most publications considered health care costs (n = 82). While 45 studies considered costs that we labelled ‘other societal costs’, these were frequently immediate costs incurred during the time frame of the intervention (e.g., costs of subsidies and social services). A third (n = 35) of the included studies considered long-term costs that occurred more than one year after birth (for interventions occurring only in pregnancy) or after the end of the intervention.
Table 3 summarizes the types of analytical approaches described in the included publications, as well as the sources of cost data, the types of costs considered, and the timeframe for included cost outcomes. The most common analytic approaches to determine the costs were through cost-effectiveness analyses (n = 43), followed by costing analyses (n = 28) and cost benefit analyses (n = 19). Cost utility (n = 8), cost consequence (n = 4) and cost-minimization (n = 1) analyses were less commonly used. The majority of analyses drew cost data from administrative health data sources (n = 77) and directly measured program costs (n = 58). Costs were also commonly sourced from the literature (n = 51). Hospital costs (n = 70) and salaries and wages (n = 62) were the most common categories of costs considered. Thirty (n = 30) analyses included costs occurring only within the duration of the intervention (immediate); 37 also included costs that occurred up to one year after birth or after the end of the intervention (short-term); and 36 also included costs that occurred longer than one year after birth or after the end of the intervention (long-term).
Discussion
The purpose of this review was to report on the state of the literature with respect to economic evaluations of interventions targeting pregnant people and/or new parents and to summarize the methods and costs used in the included studies. The 104 articles included in this review show that a range of methods, costs, and timeframes have been used to assess the value of interventions targeting pregnant people and new parents. Research on home visiting programs was most likely to consider long-term outcomes, and studies looking at long-term outcomes tended to take a wider view of the downstream costs and savings by considering long-term societal costs (e.g., costs related to child apprehension, abuse or neglect, crime, education, employment, lost productivity, addiction, etc.) in addition to program and health care costs. While we identified some economic evaluations that considered a comprehensive set of long-term societal costs, our assessment of the literature demonstrates that evaluations of interventions targeting underserved pregnant people and/or new parents frequently do not consider costs related to long-term outcomes that are necessary to assess their true value for money.
Decision-makers who fund programs targeting underserved populations need evidence to assess the potential value of investing in such programs, and the evidence gap we identified is a barrier to sustaining and spreading interventions that have the potential to improve health equity. The term value for money refers to finding an ideal balance between economy (costs), efficiency (minimizing the ratio of input to output), and effectiveness (achieving the desired outcomes), or the “three Es” [117]. Authors of several of the studies included in our scoping review acknowledge that because long-term or societal costs were not considered, their calculations represent only a small part of the economic benefit to women, infants, and families and this was often noted as a limitation of the study [41, 42, 54, 75, 87, 89]. Some authors called for further research considering these types of costs when the data or resources were available [25,26,27]. Many authors speculated that due to the limited time frame or scope of benefits considered, their calculations were likely an underestimation of the true long-term value for money of the intervention [16, 19, 21, 32, 50, 63].
Our findings align with those of other systematic reviews of economic evaluations of similar interventions [118,119,120,121,122]. In their review of economic evaluations of home visiting programs for young or vulnerable pregnant women, Stamuli et al. noted that many studies considered outcomes only within the length of the trial (what we have described as the immediate time frame) [121]. They argue that for interventions targeting vulnerable pregnant people, the benefits are expected to accrue over the lifetime of the child and the parent rather than in the immediate time frame. They recommend that these types of evaluations consider multiple perspectives, including a societal perspective, and long-term outcomes.
Ruger and Lazar (2012) systematically reviewed economic evaluations of drug abuse treatment and HIV prevention programs in pregnant women [119]. They echoed Stamuli et al.’s recommendation that costs should be reported from a societal perspective [121]. Neither Stamuli et al. [121] nor Ruger and Lazar [119] were able to reach conclusions on whether the interventions represented value for money from the results of the studies, citing a lack of consistency between studies with respect to costs considered, methods used, and perspectives taken. Both articles recommend that for best practice, detailed cost and outcome data should be collected alongside randomized control trials.
Verbeke et al.’s 2022 systematic review of the cost-effectiveness of mental health interventions during pregnancy and up to two years postpartum [122], Koegl et al.’s 2023 review of cost-benefit analyses of developmental crime prevention programs [118], and Sampaio et al.’s 2024 systematic review of interventions aimed at improving child health [120] all concluded that these interventions represented value for money. However, these authors all noted significant limitations in the literature including an overall shortage of published evaluations [118, 122], lack of consistency in methods [118, 120, 122], a deficit of data looking at outcomes for both parents and the child together [122], and insufficient analysis of the long-term effectiveness of the included interventions [118, 120, 122]. For future research, they recommend considering a broader range of outcomes for both parents as well as the child over a longer time frame. Like Stamuli et al., Verbeke et al. noted that by not considering the impact over the lifetime of the child, the real-world cost-effectiveness is likely underestimated [122].
Our results will be of value to people interested in a wide range of interventions and may assist those planning and conducting economic evaluations to improve the quality of such research. Readers can use the information provided in Table 3 to identify publications that considered long-term outcomes and societal costs and can refer to the original publications for further details regarding definitions and data sources for such costs to aid in planning their own analyses. Those planning evaluations of interventions targeting underserved pregnant people and/or new parents should collect prospective long-term outcome data pertaining to both parent and child outcomes whenever possible. Long-term health outcomes and long-term health care costs should be considered. Important long-term societal costs to consider, where relevant, include child welfare services, legal services, incarceration, other criminal justice costs, costs of crime, domestic violence, child abuse/neglect, addiction, lost productivity, employment status/income, housing, education, and earning potential. We noted a gap in the existing literature with respect to the consideration of patient priorities in the identification of costs considered. This might be addressed through patient engagement when planning economic evaluations, and through the inclusion of costs that have been identified a patient-oriented outcome measures for economic research [123]. Our findings suggest that economic evaluations that consider multiple perspectives, including a societal perspective, and a long-term time horizon will most fully describe the value for money of interventions underserved pregnant people and/or new parents. Inclusion of a patient perspective evaluation may also better address equity considerations [124].
Our scoping review is the first of its kind and has several strengths. Our method allowed us to consider grey literature and include studies of all methodologies while maintaining a systematic approach. We looked at a wider range of interventions and underserved populations than previous reviews. Another strength of our review is the extensive set of search terms used to identify underserved populations, which minimized the possibility of missing eligible articles. One limitation of our review is that we did not extract detailed information about the economic analysis methods that were used, including the outcomes associated with the full economic evaluations (e.g., quality-adjusted-life-years for cost-utility analyses, net benefit for cost-benefit analyses) and time horizons considered. Another limitation is that we did not conduct the optional stakeholder consultation step in the Arksey and O’Malley (2005) scoping review framework [12]. This step is most commonly conducted in the search phase to inform keyword selection [125]. Based on another review conducted as part of our larger program of research, we compiled an extensive set of search terms to identify relevant studies and felt confident that omission of stakeholder consultation did not sacrifice the quality of our review. Secondly, due to the nature of the scoping review methodology, we did not appraise the quality of the methods or results of the studies included in this review. Limitations and methodological concerns about some of the articles included in this review have been reported previously [34, 57, 121]. Lastly, in order to ensure included articles were relevant to our context, we did not include publications focused on interventions set outside of the top 20 GDP OECD countries. This means that the findings from this article, including the particular downstream costs considered in the analyses, may not be applicable to low- and middle-income countries.
Conclusion
This scoping review can be used to inform future economic analyses of interventions targeting poorly served pregnant people and new parents. It consolidates a list of costs that researchers and health economists may wish to consider when conducting these types of analyses and identifies studies that look at a range of downstream and long-term costs. It is important to include all costs relevant to the underserved population in question in the evaluation. Policy and resource allocation decisions are often informed by evidence generated through economic evaluations to ensure the efficient allocation of available resources. Economic evaluations that are able to capture the downstream and long-term benefits of interventions targeting underserved populations may support the implementation of policy and funding decisions that will benefit underserved pregnant people and new parents, their children, and society in general and that will reduce health inequities.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- OVID:
-
Ovid Emcare, EMBASE
- CINAHL:
-
Cumulative Index to Nursing and Allied Health Literature
- CPNP:
-
The Canada Prenatal Nutrition Program
- WIC:
-
Special Supplemental Nutrition Program for Women, Infants, and Children
- GDP:
-
Gross Domestic Product
- OECD:
-
Organisation for Economic Co-operation and Development
- HDI:
-
Human Development Index
References
Puthussery S. Perinatal outcomes among migrant mothers in the United Kingdom: is it a matter of biology, behaviour, policy, social determinants or access to health care?. Best Pract Res Clin Obstet Gynaecol. 2016;32:39–49.
Katz AS, Hardy B-J, Firestone M, Lofters A, Morton-Ninomiya ME. Vagueness, power and public health: use of ‘vulnerable‘ in public health literature. Crit Public Health. 2020;30(5):601–11.
Arabin B, Baschat A. Pregnancy: an underutilized window of opportunity to improve long-term maternal and infant health - an appeal for continuous family care and interdisciplinary communication. Front Pediatr. 2017;5:69.
McAuliffe F. Impact of pregnancy on long-term health: advances in postpregnancy care - An opportunity to improve long-term maternal health. Int J Gynecol Obstet. 2023;160:4–6.
Gaillard R, Wright J, Jaddoe VWV. Lifestyle intervention strategies in early life to improve pregnancy outcomes and long-term health of offspring: a narrative review. J Dev Orig Health Dis. 2019;10(3):314–21.
Ranson K, Urichuk L. The effect of parent–child attachment relationships on child biopsychosocial outcomes: a review. Early Child Dev Care. 2008;178(2):129–52.
McRae DNMN, Stoll K, Mayhew M, Vedam S, Mpofu D, Janssen PA. Is model of care associated with infant birth outcomes among vulnerable women? A scoping review of midwifery-led versus physician-led care. SSM Popul Health. 2016;2:182–93.
Sandall J, Soltani H, Gates S, Shennan A, Devane D. Midwife-led continuity models versus other models of care for childbearing women. Cochrane Database Syst Rev. 2016;4(4):Cd004667.
Balaam M-C, Thomson G. Building capacity and wellbeing in vulnerable/marginalised mothers: a qualitative study. Women Birth. 2018;31(5):e341–7.
McRae DN, Janssen PA, Vedam S, Mayhew M, Mpofu D, Teucher U, et al. Reduced prevalence of small-for-gestational-age and preterm birth for women of low socioeconomic position: a population-based cohort study comparing antenatal midwifery and physician models of care. BMJ Open. 2018;8(10):e022220.
McRae DN, Muhajarine N, Janssen PA. Improving birth outcomes for women who are substance using or have mental illness: a Canadian cohort study comparing antenatal midwifery and physician models of care for women of low socioeconomic position. BMC Pregnancy Childbirth. 2019;19(1):279.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
GDP per capita and productivity levels. 2020. Available from: https://www.oecd-ilibrary.org/content/data/data-00686-en. Cited 20 May 2020.
Ammerman RT, Mallow PJ, Rizzo JA, Putnam FW, Van Ginkel JB. Cost-effectiveness of In-Home Cognitive Behavioral Therapy for low-income depressed mothers participating in early childhood prevention programs. J Affect Disord. 2017;208:475–82.
Aos S, Lieb R, Mayfield J, Miller M, Pennucci A. Benefits and costs of prevention and early intervention programs for youth. 2004.
Avruch S, Cackley AP. Savings achieved by giving WIC benefits to women prenatally. Public Health Rep. 1995;110(1):27–34.
Bacheller HL, Hersh AR, Caughey AB. Behavioral smoking cessation counseling during pregnancy: a cost-effectiveness analysis. Obstet Gynecol. 2021;137(4):703–12.
Bensussen-Walls W, Saewyc EM. Teen-focused care versus adult-focused care for the high-risk pregnant adolescent: an outcomes evaluation. Public Health Nurs. 2001;18(6):424–35.
Berkowitz G, Brindis C, Clayson Z, Peterson S. Options for recovery: Promoting success among women mandated to treatment. J Psychoactive Drugs. 1996;28(1):31–8.
Brumfield CG, Nelson KG, Stotser D, Yarbaugh D, Patterson P, Sprayberry NK. 24-Hour mother-infant discharge with a follow-up home health visit: results in a selected medicaid population. Obstet Gynecol. 1996;88(4 I):544–8.
Buescher PA, Horton SJ. Prenatal WIC participation in relation to low birth weight and medicaid infant costs in North Carolina – A 1997 update. 2000.
Buescher PA, Larson LC, Nelson MD Jr, Lenihan AJ. Prenatal WIC participation can reduce low birth weight and newborn medical costs: a cost-benefit analysis of WIC participation in North Carolina. J Am Diet Assoc. 1993;93(2):163–6.
Burchard J, Markenson GR, Saade GR, Laurent LC, Heyborne KD, Coonrod DV, et al. Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort. J Med Econ. 2022;25(1):1255–66.
Burger S. A cost consequence analysis of outreach strategies for high risk pregnant women. J Community Health Nurs. 2010;27(3):137–45.
Cramer ME, Chen L-W, Roberts S, Clute D. Evaluating the social and economic impact of community-based prenatal care. Public Health Nurs. 2007;24(4):329–36.
Daley M, Argeriou M, McCarty D, Callahan JJ Jr, Shepard DS, Williams CN. The costs of crime and the benefits of substance abuse treatment for pregnant women. J Subst Abuse Treat. 2000;19(4):445–58.
Daley M, Argeriou M, McCarty D, Callahan JJ Jr, Shepard DS, Williams CN. The impact of substance abuse treatment modality on birth weight and health care expenditures. J Psychoactive Drugs. 2001;33(1):57–66.
Daley M, Shepard DS, Bury-Maynard D. Changes in quality of life for pregnant women in substance user treatment: developing a quality of life index for the addictions. Subst Use Misuse. 2005;40(3):375–94.
Devaney B, Bilheimer L, Schore J. Medicaid costs and birth outcomes: The effects of prenatal WIC participation and the use of prenatal care. J Policy Anal Manage. 1992;11(4):573–92.
Dornelas EA, Magnavita J, Beazoglou T, Fischer EH, Oncken C, Lando H, et al. Efficacy and cost-effectiveness of a clinic-based counseling intervention tested in an ethnically diverse sample of pregnant smokers. Patient Educ Couns. 2006;64(1–3):342–9.
Dumont K, Kirkland K, Mitchell-Herzfeld S, Ehrhard-Dietzel S, Rodriguez LM, Lee E, et al. A randomized trial of Healthy Families New York (HFNY): does home visiting prevent child maltreatment? New York: New York State Office of Children andFamily Services University at Albany, State University of New York; 2010. October 31, 2010. Contract No.: 232945.
French MT, McCollister KE, Cacciola J, Durell J, Stephens RL. Benefit-cost analysis of addiction treatment in Arkansas: specialty and standard residential programs for pregnant and parenting women. Substance Abuse. 2002;23(1):31–51.
Gareau S, Lòpez-De Fede A, Loudermilk BL, Cummings TH, Hardin JW, Picklesimer AH, et al. Group prenatal care results in Medicaid savings with better outcomes: a propensity score analysis of CenteringPregnancy participation in South Carolina. Matern Child Health J. 2016;20(7):1384–93.
Glazner J, Bondy J, Luckey D, Olds D. Effect of the nurse family partnership on Government expenditures for vulnerable first-time mothers and their children in Elmira, New York. Memphis: Tennessee, and Denver, Colorado. [Internet]. Colorado: University of Colorado Health Sciences Center; 2004. Available from: https://www.acf.hhs.gov/sites/default/files/documents/opre/effect_nursefam.pdf.
Goler NC, Armstrong MA, Osejo VM, Hung Y-Y, Haimowitz M, Caughey AB. Early start: a cost-beneficial perinatal substance abuse program. Obstet Gynecol. 2012;119(1):102–10.
Graveley EA, Littlefield JH. A cost-effectiveness analysis of three staffing models for the delivery of low-risk prenatal care. Am J Public Health. 1992;82(2):180–4.
Gregory PM, de Jesus ML. Racial differences in birth outcomes and costs in relation to prenatal WIC participation. N J Med. 2003;100(3):29–36.
Grote NK, Simon GE, Russo J, Lohr MJ, Carson K, Katon W. Incremental benefit-Cost of MOMCare: Collaborative care for perinatal depression among economically disadvantaged women. Psychiatr Serv. 2017;68(11):1164–71.
Guo Y, Lee J-A, Rousseau J, Pimentel P, Bojorquez Y, Cabasag C, et al. The potential economic impact of a coordinated home visitation program: preventing adverse birth outcomes. Calif J Health Promot. 2016;14(2):1–13.
Hannan J, Brooten D, Page T, Galindo A, Torres M. Low-income first-time mothers: effects of APN follow-up using mobile technology on maternal and infant outcomes. Global Pediatric Health. 2016;3:2333794X16660234.
Howell E, Palmer A, Benatar S, Garrett B. Potential medicaid cost savings from maternity care based at a Freestanding Birth Center. Medicare Medicaid Res Rev. 2014;4(3):mmrr2014-004-03-a06.
Hueston WJ, Quattlebaum RG, Benich JJ. How much money can early prenatal care for teen pregnancies save?: a cost-benefit analysis. J Am Board Fam Med. 2008;21(3):184–90.
Johnson JE, Wiltsey-Stirman S, Sikorskii A, Miller T, King A, Blume JL, et al. Protocol for the ROSE sustainment (ROSES) study, a sequential multiple assignment randomized trial to determine the minimum necessary intervention to maintain a postpartum depression prevention program in prenatal clinics serving low-income women. Implement Sci. 2018;13(1):N.PAG-N.PAG.
Joyce T, Corman H, Grossman M. A cost-effectiveness analysis of strategies to reduce infant mortality. Med Care. 1988;26(4):348–60.
Karoly LA, Greenwood PW, Sohler Everingham SM, Hoube J, Kilburn MR, Rydell CP, et al. Investing in our children: what we know and don’t know about the costs and benefits of early childhood interventions. Santa Monica, CA: RAND Corporation; 1998.
Lee S, Aos S, Miller M. Evidence-based programs to prevent children from entering and remaining in the child welfare system: benefits and costs for Washington. 2008.
Leppert PC, Namerow PB. Cost averted by providing comprehensive prenatal care to teenagers. J Nurse Midwifery. 1985;30(5):285–9.
Lopez-Soto D, Griffin PM. Estimating the impact of neonatal abstinence system interventions on Medicaid: an incremental cost analysis. Subst Abuse Treat Prev Policy. 2021;16(1):91.
Lu MC, Lin YG, Prietto NM, Garite TJ. Elimination of public funding of prenatal care for undocumented immigrants in California: a cost/benefit analysis. Am J Obstet Gynecol. 2000;182(1 Pt 1):233–9.
McCallum DM, Fosson GH, Pisu M. Making the case for medicaid funding of smoking cessation treatment programs: an application to state-level health care savings. J Health Care Poor Underserved. 2014;25(4):1922–40.
McDonald GJ, Fenstermaker CR, Bellis DDA, Sheila K Cosgrove, James C Cackley, Alicia Puente Deroy C. Robert, Cassady MER, Janice S. Early intervention: federal investments like WIC can produce savings. 1992.
Miller TR. Projected outcomes of nurse-family partnership home visitation during 1996–2013, USA. Prev Sci. 2015;16(6):765–77.
Montgomery DL, Splett PL. Economic benefit of breast-feeding infants enrolled in WIC. J Am Diet Assoc. 1997;97(4):379–85.
Moore TR, Origel W, Key TC, Resnik R. The perinatal and economic impact of prenatal care in a low-socioeconomic population. Am J Obstet Gynecol. 1986;154(1):29–33.
Mundt MP, Fiore MC, Piper ME, Adsit RT, Kobinsky KH, Alaniz KM, et al. Cost-effectiveness of stop smoking incentives for medicaid-enrolled pregnant women. Prev Med. 2021;153:106777.
Nehme EK, Wilson KJ, McGowan R, Schuessler KR, Morse SM, Patel DA. Providing doula support to publicly insured women in central Texas: a financial cost–benefit analysis. Birth. 2024;51(1):63–70.
Olds D, Miller TR, Knudtson M, Luckey D, Bondy J, Stevenson A, et al. Impact of the nurse-family partnership on neighborhood context, government expenditures, and children’s school functioning. 2011.
Olds DL, Henderson CR Jr, Phelps C, Kitzman H, Hanks C. Effect of prenatal and infancy nurse home visitation on government spending. Med Care. 1993;31(2):155–74.
Olds DL, Kitzman H, Anson E, Smith JA, Knudtson MD, Miller T, et al. Prenatal and infancy nurse home visiting effects on mothers: 18-year follow-up of a randomized trial. Pediatrics. 2019;144(6):e20183889.
Olds DL, Kitzman HJ, Cole RE, Hanks CA, Arcoleo KJ, Anson EA, et al. Enduring effects of prenatal and infancy home visiting by nurses on maternal life course and government spending: follow-up of a randomized trial among children at age 12 years. Arch Pediatr Adolesc Med. 2010;164(5):419–24.
Parker DR, Windsor RA, Roberts MB, Hecht J, Hardy NV, Strolla LO, et al. Feasibility, cost, and cost-effectiveness of a telephone-based motivational intervention for underserved pregnant smokers. Nicotine Tob Res. 2007;9(10):1043–51.
Pollack HA. Sudden infant death syndrome, maternal smoking during pregnancy, and the cost-effectiveness of smoking cessation intervention. Am J Public Health. 2001;91(3):432–6.
Pugh LC, Milligan RA, Frick KD, Spatz D, Bronner Y. Breastfeeding duration, costs, and benefits of a support program for low-income breastfeeding women. Birth. 2002;29(2):95–100.
Reid ML, Morris JB. Perinatal care and cost effectiveness: changes in health expenditures and birth outcome following the establishment of a nurse-midwife program. Med Care. 1979;17(5):491–500.
Rodriguez MI, Swartz JJ, Lawrence D, Caughey AB. Extending delivery coverage to include prenatal care for low-income, immigrant women is a cost-effective strategy. In: Women’s health issues. 2020.
Rowley RA, Phillips LE, O’Dell L, El Husseini R, Carpino S, Hartman S. Group prenatal care: a financial perspective. Matern Child Health J. 2016;20(1):1–10.
Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Value in Health. 2008;11(2):191–8.
Saygın Avşar T, Jackson L, Barton P, Jones M, McLeod H. Towards optimum smoking cessation interventions during pregnancy: a household model to explore cost-effectiveness. Addiction. 2022;117(10):2707–19.
Seiner K, Lairson DR. A cost-effectiveness analysis of prenatal care delivery. Eval Health Prof. 1985;8(1):93–108.
Svikis DS, Golden AS, Huggins GR, Pickens RW, McCaul ME, Velez ML, et al. Cost-effectiveness of treatment for drug-abusing pregnant women. Drug Alcohol Depend. 1997;45(1–2):105–13.
Thorsen N, Khalil L. Cost savings associated with smoking cessation for low-income pregnant women. Wis Med J. 2004;103(5):67.
Tuttle CR, Dewey KG. Potential cost savings for Medi-Cal, AFDC, food stamps, and WIC programs associated with increasing breast-feeding among low-income Hmong women in California. J Am Diet Assoc. 1996;96(9):885–90.
Washington State Institute for Public Policy. Nurse family partnership - public health & prevention: home- or family-based benefit-cost estimates updated December 2023. Olympia: Washington State Institute for Public Policy; 2023.
Wilkinson A, Anderson S, Wheeler SB. Screening for and treating postpartum depression and psychosis: a cost-effectiveness analysis. Matern Child Health J. 2017;21(4):903–14.
Windsor RA, Lowe JB, Perkins LL, Smith-Yoder D, Artz L, Crawford M, et al. Health education for pregnant smokers: its behavioral impact and cost benefit. Am J Public Health. 1993;83(2):201–6.
Wu J, Dean KS, Rosen Z, Muennig PA. The cost-effectiveness analysis of nurse-family partnership in the United States. J Health Care Poor Underserved. 2017;28(4):1578–97.
Xu X, Yonkers KA, Ruger JP. Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):83.
Barlow J, Beake S, Bick D, Bryson C, Day L, Gilby N, et al. Initial protocol for a national evaluation of an area-based intervention programme (A Better Start) on early-life outcomes: a longitudinal cohort study with comparison (control) cohort samples. BMJ Open. 2017;7(8):e015086.
Barlow J, Sembi S, Parsons H, Kim S, Petrou S, Harnett P, et al. A randomized controlled trial and economic evaluation of the Parents Under Pressure program for parents in substance abuse treatment. Drug Alcohol Depend. 2019;194:184–94.
Barnes J, Stuart J, Allen E, Petrou S, Sturgess J, Barlow J, et al. Randomized controlled trial and economic evaluation of nurse-led group support for young mothers during pregnancy and the first year postpartum versus usual care. Trials. 2017;18:1–15.
Bell K, Corbacho B, Ronaldson S, Richardson G, Hood K, Sanders J, et al. Costs and consequences of the Family Nurse Partnership (FNP) programme in England: evidence from the building blocks trial. F1000Research. 2019;8:1640.
Bell R, Glinianaia SV, Waal ZV, Close A, Moloney E, Jones S, et al. Evaluation of a complex healthcare intervention to increase smoking cessation in pregnant women: interrupted time series analysis with economic evaluation. Tob Control. 2018;27(1):90–8.
Bick D, Taylor C, Avery A, Bhavnani V, Craig V, Healey A, et al. Protocol for a two-arm feasibility RCT to support postnatal maternal weight management and positive lifestyle behaviour in women from an ethnically diverse inner city population: the SWAN feasibility trial. Pilot Feasibility Stud. 2019;5(1):117.
Boath E, Major K, Cox J. When the cradle falls II: The cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care. J Affect Disord. 2003;74(2):159–66.
Boyd KA, Briggs AH, Bauld L, Sinclair L, Tappin D. Are financial incentives cost-effective to support smoking cessation during pregnancy?. Addiction. 2016;111(2):360–70.
Coleman T, Clark M, Welch C, Whitemore R, Leonardi-Bee J, Cooper S, et al. Effectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta-analysis. Addiction. 2022;117(4):1079–94.
Corbacho B, Bell K, Stamuli E, Richardson G, Ronaldson S, Hood K, et al. Cost-effectiveness of the Family Nurse Partnership (FNP) programme in England: evidence from the building blocks trial. J Eval Clin Pract. 2017;23(6):1367–74.
Dundas R, Boroujerdi M, Browne S, Deidda M, Bradshaw P, Craig P, et al. Evaluation of the Healthy Start voucher scheme on maternal vitamin use and child breastfeeding: a natural experiment using data linkage. Public Health Res (Southampt). 2023;11(11):1–101.
Essex HN, Parrott S, Wu Q, Li J, Cooper S, Coleman T. Cost-effectiveness of nicotine patches for smoking cessation in pregnancy: A placebo randomized controlled trial (SNAP). Nicotine Tob Res. 2015;17(6):636–42.
Hoddinott P, Craig L, Maclennan G, Boyers D, Vale L. The FEeding Support Team (FEST) randomised, controlled feasibility trial of proactive and reactive telephone support for breastfeeding women living in disadvantaged areas. BMJ open. 2012;2(2):e000652.
Howard LM, Trevillion K, Potts L, Heslin M, Pickles A, Byford S, Carson LE, Dolman C, Jennings S, Johnson S, Jones I, McDonald R, Pawlby S, Powell C, Seneviratne G, Shallcross R, Stanley N, Wieck A, Abel KM. Effectiveness and cost-effectiveness of psychiatric mother and baby units: quasi-experimental study. Br J Psychiatry. 2022;221(4):628–36. https://doi.org/10.1192/bjp.2022.48.
Jones M, Smith M, Lewis S, Parrott S, Coleman T. A dynamic, modifiable model for estimating cost-effectiveness of smoking cessation interventions in pregnancy: application to an RCT of self-help delivered by text message. Addiction. 2019;114(2):353–65.
Jones M, Smith M, Lewis S, Parrott S, Coleman T. Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model. Addiction. 2022;117(11):2907–17.
Longhi E, Murray L, Hunter R, Wellsted D, Taylor-Colls S, Mackenzie K, et al. The NSPCC UK Minding the Baby® (MTB) home-visiting programme, supporting young mothers (aged 14–25) in the first 2 years of their baby's life: Study protocol for a randomised controlled trial. Trials. 2016;17:486.
McIntosh E, Barlow J, Davis H, Stewart-Brown S. Economic evaluation of an intensive home visiting programme for vulnerable families: a cost-effectiveness analysis of a public health intervention. J Public Health. 2009;31(3):423–33.
McMeekin N, Sinclair L, Robinson-Smith L, Mitchell A, Bauld L, Tappin DM, et al. Financial incentives for quitting smoking in pregnancy: are they cost-effective?. Addiction. 2023;118(8):1445–56.
Morrell CJ, Warner R, Slade P, Dixon S, Walters S, Paley G, et al. Psychological interventions for postnatal depression: cluster randomised trial and economic evaluation. The PoNDER trial. Health Technol Assess. 2009;13(30):iii-iv, xi-xiii, 1–153.
Naughton F, Cooper S, Foster K, Emery J, Leonardi-Bee J, Sutton S, et al. Large multi-centre pilot randomized controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit). Addiction. 2017;112(7):1238–49.
Petrou S, Cooper P, Murray L, Davidson LL. Cost-effectiveness of a preventive counseling and support package for postnatal depression. Int J Technol Assess Health Care. 2006;22(4):443–53.
Poston L, Bell R, Briley AL, Godfrey KM, Nelson SM, Oteng-Ntim E, et al. Improving pregnancy outcome in obese women: the UK pregnancies better eating and activity randomised controlled trial. Southampton (UK): NIHR Journals Library; 2017.
Stevenson MD, Scope A, Sutcliffe PA. The cost-effectiveness of group cognitive behavioral therapy compared with routine primary care for women with postnatal depression in the UK. Value Health. 2010;13(5):580–4.
Trevillion K, Ryan EG, Pickles A, Heslin M, Byford S, Nath S, et al. An exploratory parallel-group randomised controlled trial of antenatal Guided Self-Help (plus usual care) versus usual care alone for pregnant women with depression: DAWN trial. J Affect Disord. 2020;261:187–97.
Ussher M, Lewis S, Aveyard P, Manyonda I, West R, Lewis B, et al. The London Exercise And Pregnant smokers (LEAP) trial: a randomised controlled trial of physical activity for smoking cessation in pregnancy with an economic evaluation. Health Technol Assess. 2015;19(84):vii–xxiv, 1–135.
Wiggins M, Oakley A, Roberts I, Turner H, Rajan L, Austerberry H, Mujica R, Mugford M. The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. Health Technol Assess. 2004;8(32):iii, ix-x, 1-120. https://doi.org/10.3310/hta8320.
Wiggins M, Sawtell M, Wiseman O, McCourt C, Eldridge S, Hunter R, et al. Group antenatal care (Pregnancy Circles) for diverse and disadvantaged women: study protocol for a randomised controlled trial with integral process and economic evaluations. BMC Health Serv Res. 2020;20(1):919.
Wilson GB, McGovern R, Antony G, Cassidy P, Deverill M, Graybill E, et al. Brief intervention to reduce risky drinking in pregnancy: study protocol for a randomized controlled trial. Trials. 2012;13(1):174-.
Centre of Perinatal Excellence. Valuing perinatal mental health: the consequences of not treating perinatal depression and anxiety. 2014.
Gao Y, Roe Y, Hickey S, Chadha A, Kruske S, Nelson C, et al. Birthing on country service compared to standard care for First Nations Australians: a cost-effectiveness analysis from a health system perspective. Lancet Reg Health West Pac. 2023;34:100722-.
Hickey S, Roe Y, Gao Y, Nelson C, Carson A, Currie J, et al. The indigenous birthing in an urban setting study: the IBUS study: a prospective birth cohort study comparing different models of care for women having Aboriginal and Torres Strait Islander babies at two major maternity hospitals in urban South East Queensland, Australia. BMC Pregnancy Childbirth. 2018;18(1):431.
Hodgins M, Ostojic K, Hu N, Lawson KD, Samir N, Webster A, et al. Study protocol for a real-world evaluation of an integrated child and family health hub for migrant and refugee women. BMJ open. 2022;12(8):e061002-e.
Jan S, Conaty S, Hecker R, Bartlett M, Delaney S, Capon T. An holistic economic evaluation of an Aboriginal community-controlled midwifery programme in Western Sydney. J Health Serv Res Policy. 2004;9(1):14–21.
Riggs E, Yelland J, Mensah FK, Gold L, Szwarc J, Kaplan I, et al. Group Pregnancy Care for refugee background women: a codesigned, multimethod evaluation protocol applying a community engagement framework and an interrupted time series design. BMJ Open. 2021;11(7):e048271.
Keshmiri R, Coyte PC, Laporte A, Sheth PM, Loutfy M. Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV. Medicine. 2019;98(23):e15841.
McMurchy D, Palmer R, Thornton M, Birdi T. An assessment of the economic impact of the Canada Prenatal Nutrition Program (CPNP). 2009.
Thanh NX, Jonsson E, Moffatt J, Dennett L, Chuck AW, Birchard S. An economic evaluation of the parent-child assistance program for preventing fetal alcohol spectrum disorder in Alberta. Canada Adm Policy Ment Health. 2015;42(1):10–8.
(FRA) EUAfFR. Cost of exclusion from healthcare : the case of migrants in an irregular situation. 2015.
Jackson P. Value for money and international development: deconstructing myths to promote a more constructive discussion. eVALUation Matters. 2012;3:8–15.
Koegl CJ, Farrington DP, Welsh BC. Cost-benefit analyses of developmental crime prevention programmes. Crim Behav Ment Health. 2023;33(2):106–15.
Ruger J, Lazar C. Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review. Addict Behav. 2012;37(1):1–10.
Sampaio F, Nystrand C, Feldman I, Mihalopoulos C. Evidence for investing in parenting interventions aiming to improve child health: a systematic review of economic evaluations. Eur Child Adolesc Psychiatry. 2024;33(2):323–55.
Stamuli E, Richardson G, Duffy S, Robling M, Hood K. Systematic review of the economic evidence on home visitation programmes for vulnerable pregnant women. Br Med Bull. 2015;115(1):19–44.
Verbeke E, Bogaerts A, Nuyts T, Crombag N, Luyten J. Cost-effectiveness of mental health interventions during and after pregnancy: a systematic review. Birth. 2022;49(3):364–402.
Brown D, Srinivasan M, Arbulu L, Dullabh R, Curtis K, Zott C, et al. Federal data for conducting patient-centered outcomes research on economic outcomes. Med Care. 2023;61(7):462–9.
Fu R, Ng V, Liu M, Wells D, Yurga E, Nauenberg E. Considering patient perspectives in economic evaluations of health interventions. Front Public Health. 2023;11:1212583.
Pham MT, Rajic A, Greig JD, Sargeant JM, Papadopoulos A, McEwen SA. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods. 2014;5(4):371–85.
Acknowledgements
We acknowledge the contributions of Riley Graybrook to the data acquisition process and Bella Arless to updating the searches in 2024, screening results, and extracting data, and the support of Lindsay Grenier in preparing the final manuscript for submission. We thank Emmanuel Guindon for his review of an earlier version of the manuscript.
Funding
This research was funded by a grant from the Canadian Institutes of Health Research (#MRC-167971) awarded to Elizabeth Darling (PI). Aisha Jansen was also supported by a Mitacs Research Training Award. The funders had no role in study design; in the collection, analysis and interpretation of data; in writing of the report; or in the decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
The study was conceptualized by E.D. E.D., J-E.T., and A.J. contributed to the study design. A.J. and B.J. conducted the study selection and full text screening, and A.J. completed the data extraction. E.D. was consulted when consensus could not be reached. The findings were collated and summarized by A.J. The first draft of the manuscript was written by A.J. and E.D. All authors critically revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not Applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Darling, E.K., Jansen, A., Jameel, B. et al. A scoping review of costing methodologies used to assess interventions for underserved pregnant people and new parents. Int J Equity Health 23, 168 (2024). https://doi.org/10.1186/s12939-024-02252-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12939-024-02252-x